Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale

Diacerein orphan drug development for epidermolysis bullosa simplex: A phase 2/3 randomized, placebo-controlled, double-blind clinical trial

(2018) Verena Wally et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Betulin wound gel accelerated healing of superficial partial thickness burns: Results of a randomized, intra‐individually controlled, phase III trial with 12‐months follow‐up

(2018) Quentin Frew et al.   BURNS

219 Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa

(2017) D. Solis et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification

(2014) Jo-David Fine et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Prevalence and Characterization of Pruritus in Epidermolysis Bullosa

(2014) Christina Danial et al.   PEDIATRIC DERMATOLOGY

Instrument for Scoring Clinical Outcome of Research for Epidermolysis Bullosa: A Consensus-Generated Clinical Research Tool

(2014) Agnes Schwieger-Briel et al.   PEDIATRIC DERMATOLOGY

From a Traditional Medicinal Plant to a Rational Drug: Understanding the Clinically Proven Wound Healing Efficacy of Birch Bark Extract

(2014) Sandra Ebeling et al.   PLoS One

The “Wound-QoL”: A short questionnaire measuring quality of life in patients with chronic wounds based on three established disease-specific instruments

(2014) Christine Blome et al.   WOUND REPAIR AND REGENERATION

Itch Assessment Scale for the Pediatric Burn Survivor

(2012) Vershanna Morris et al.   Journal of Burn Care & Research

PRM111 Pediatric Patient-Reported Outcomes Assessment: A Case Study in Epidermolysis Bullosa

(2012) M. Mordin et al.   VALUE IN HEALTH

Measurement of itching: Validation of the Leuven Itch Scale

(2011) Chris Haest et al.   BURNS

The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: A feasibility trial

(2011) Irene Lara-Corrales et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The challenge of using randomized trials in wound healing

(2010) F. Gottrup et al.   BRITISH JOURNAL OF SURGERY

Pharmacokinetics of dipeptidylpeptidase-4 inhibitors

(2010) A. J. Scheen   DIABETES OBESITY & METABOLISM

Responsiveness of nonHerlitz Junctional Epidermolysis Bullosa to topical gentian violet

(2010) Supriya S. Venugopal et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Inherited epidermolysis bullosa

(2010) Jo-David Fine   Orphanet Journal of Rare Diseases

Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer

(2010) Vivek R. Yadav et al.   Toxins

Validation of the Wong-Baker FACES Pain Rating Scale in Pediatric Emergency Department Patients

(2009) Gregory Garra et al.   ACADEMIC EMERGENCY MEDICINE

Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument

(2009) J.W. Frew et al.   BRITISH JOURNAL OF DERMATOLOGY

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

(2009) Murtuza Bharmal et al.   Health and Quality of Life Outcomes

Triterpenes Promote Keratinocyte Differentiation In Vitro, Ex Vivo and In Vivo: A Role for the Transient Receptor Potential Canonical (subtype) 6

(2009) Ute Woelfle et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY